Daily policy & regulation roundup: 6 stories curated September 17, 2026. Lead: FDA, Sanofi, Gilead Weigh AI Readiness and Validation Risk at PDA/FDA Conference.

The latest in policy & regulation: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: FDA, Sanofi, Gilead Weigh AI Readiness and Validation Risk at PDA/FDA Conference.
As Medicare Advantage denial rates climb, health systems are dropping plans and steering patients back to traditional Medicare. Pearl Health CEO Michael Kopko thinks the original Medicare Advantage bargain has broken down — and that the model may never have been as efficient as policymakers assumed. The post As MA Denial Rates Rise, Hospitals Are Betting on Traditional Medicare Instead appear…
Follow the full firehose on the HTC Wire, refreshed automatically every day.